BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients
L. Wang, Q. Chunyan, Yuehua Zhou, Quan-Yao He, Yu-ru MA, Y. Ga, X. Wang
Abstract
The article “BCAR4 increase cisplatin resistance and predicted poor survival in gastric cancer patients, by L. Wang, Q. Chunyan, Y. Zhou, Q. He, Y. Ma, Y. Ga, X. Wang, published in Eur Rev Med Pharmacol Sci 2017; 21 (18): 4064-4070–PMID: 29028095” has been withdrawn from the authors due to incorrect data in the conclusions. The authors are performing further experiments and they found some novelties. Therefore, they hope to re-write and conceive the paper to better clarify their findings.\nThe Publisher apologizes for any inconvenience this may cause.\nhttps://www.europeanreview.org/article/13420
Topics & Concepts
CisplatinCancerInternal medicineOncologyMedicineResistance (ecology)Cancer survivalBiologyChemotherapyEcologyCancer Research and TreatmentsPeptidase Inhibition and AnalysisMelanoma and MAPK Pathways